Liu An, Li Fei, Wang Bao, Yang Le, Xing Hai, Su Chang, Gao Li, Zhao Minggao, Luo Lanxin
Precision Pharmacy and Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Department of Pharmacy, The Hospital of 92880 Troops, PLA Navy, Zhoushan, Zhejiang, China.
Front Pharmacol. 2022 Dec 14;13:1055841. doi: 10.3389/fphar.2022.1055841. eCollection 2022.
Calcium signaling is implicated in multiple processes including immune response that important in tumor progression. Kidney renal clear cell carcinoma (KIRC) is the most frequent histological type of renal cell carcinoma with up to a third of cases develop metastases. As a result of a lack of in-depth understanding of the mechanisms underlying KIRC, treatment options have been limited. Here, we aim to comprehensively investigate the landscape of Ca channels, pumps and exchangers in KIRC patients. The mRNA expression profiles and gene variations of 58 calcium-related genes (CRGs) in KIRC patients and normal control cases were downloaded from TCGA database. CRGs-related risk score was constructed to quantify calcium patterns by using least absolute shrinkage and selection operator (LASSO) regression. The prognostic value, biological functions, immune landscape and therapeutic sensitivities based on CRGs-related risk score were then evaluated using multiple methods. Finally, key gene of CRGs was identified by weighted gene co-expression network analysis (WGCNA). TCGA-CPTAC, GSE53757 datasets, as well as human tissues were used for validation. KIRC patients had significant differences in CRG expression, prognosis, and biological functions between two CRG clusters. CRGs-related risk score was then determined. The prognosis, tumor mutation burden, immune cell infiltration, immune checkpoints, and the response of targeted inhibitors were remarkably different between high and low CRGs-related risk subtypes. CRGs-related high-risk subtype was characterized by immunosuppressive microenvironment with poor prognosis. Meanwhile, several targeted drugs showed distinct sensitivity between CRGs-related risk subtypes. Finally, TRPM3 was identified as a key CRG based on risk score in KIRC patients. TRPM3 mRNA and protein expression were significantly lower in KIRC tumors than in normal controls. Low TRPM3 expression was associated with poor prognosis in KIRC patients. Our study highlighted the promising prognostic value of CRGs in KIRC tumors. The evaluation of CRGs-related risk score will contribute to predicting prognosis and clinical therapy in KIRC patients.
钙信号传导参与包括免疫反应在内的多个过程,而免疫反应在肿瘤进展中很重要。肾透明细胞癌(KIRC)是肾细胞癌最常见的组织学类型,高达三分之一的病例会发生转移。由于对KIRC潜在机制缺乏深入了解,治疗选择有限。在此,我们旨在全面研究KIRC患者中钙通道、泵和交换体的情况。从TCGA数据库下载了KIRC患者和正常对照病例中58个钙相关基因(CRG)的mRNA表达谱和基因变异。通过使用最小绝对收缩和选择算子(LASSO)回归构建CRG相关风险评分,以量化钙模式。然后使用多种方法评估基于CRG相关风险评分的预后价值、生物学功能、免疫情况和治疗敏感性。最后,通过加权基因共表达网络分析(WGCNA)确定CRG的关键基因。使用TCGA-CPTAC、GSE53757数据集以及人体组织进行验证。KIRC患者在两个CRG簇之间的CRG表达、预后和生物学功能存在显著差异。然后确定了CRG相关风险评分。高、低CRG相关风险亚型在预后、肿瘤突变负荷、免疫细胞浸润、免疫检查点以及靶向抑制剂反应方面存在显著差异。CRG相关高风险亚型的特征是免疫抑制微环境,预后较差。同时,几种靶向药物在CRG相关风险亚型之间表现出明显的敏感性差异。最后,基于KIRC患者的风险评分,确定TRPM3为关键CRG。KIRC肿瘤中TRPM3 mRNA和蛋白表达明显低于正常对照。KIRC患者中TRPM3低表达与预后不良相关。我们的研究突出了CRG在KIRC肿瘤中具有前景的预后价值。评估CRG相关风险评分将有助于预测KIRC患者预后和临床治疗。